Insider trades
Klein Matthew B., Director of ClearPoint Neuro CLPT, has filed 0 purchases and 29 sales on the open market. Over the past 12 months that comes to a net sale of $3.7M. The latest trade was on 05/21.
Klein Matthew B.
Director
- Company
- ClearPoint Neuro CLPT
- First filing
- 23/01/09
- Trades
- 54 trades
- Buys / sales
- 0 / 29
- 12-month net buying
- −$3.7M
- Last trade
- 05/21
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
ClearPoint NeuroCLPT | Open-market sale | 05/21 | 05/26 | 16,000 sh | $11.59 | $185,440 | −25.4% |
PTCT | Open-market sale10b5-1 plan | 05/14 | 05/15 | 12,572 sh4 trades | $72.95avg. | $917,153.54 | −3.1% |
PTC TherapeuticsPTCT | Open-market sale10b5-1 plan | 04/21 | 04/23 | 2,850 sh | $70.91 | $202,093.5 | −0.7% |
PTC TherapeuticsPTCT | Open-market sale10b5-1 plan | 03/12 | 03/13 | 2,662 sh | $64.08 | $170,580.96 | −0.7% |
PTC TherapeuticsPTCT | Open-market sale10b5-1 plan | 02/18 | 02/20 | 7,371 sh | $69.36 | $511,252.56 | −1.9% |
PTC TherapeuticsPTCT | Open-market sale10b5-1 plan | 01/08 | 01/12 | 2,514 sh | $76.45 | $192,195.3 | −0.6% |
PTCT | Open-market sale10b5-1 plan | 01/06–01/07 | 01/08 | 8,165 sh2 trades | $77.15avg. | $629,895.23 | −2.0% |
PTC TherapeuticsPTCT | Open-market sale10b5-1 plan | 25/12/30 | 01/02 | 8,089 sh | $76.64 | $619,940.96 | −2.3% |
PTC TherapeuticsPTCT | Open-market sale10b5-1 plan | 25/12/02 | 25/12/03 | 3,428 sh | $79.07 | $271,051.96 | −1.0% |
PTC TherapeuticsPTCT | Open-market sale10b5-1 plan | 25/08/05 | 25/08/05 | 10,739 sh | $51.74 | $555,635.86 | −3.1% |
PTC TherapeuticsPTCT | Open-market sale10b5-1 plan | 25/04/22 | 25/04/24 | 2,804 sh | $48.74 | $136,666.96 | −1.0% |
PTCT | Open-market sale10b5-1 plan | 25/02/19–25/02/20 | 25/02/21 | 7,792 sh2 trades | $50.11avg. | $390,457.1 | −2.7% |
PTCT | Open-market sale10b5-1 plan | 25/01/07–25/01/08 | 25/01/10 | 4,544 sh2 trades | $44.90avg. | $204,007.28 | −1.6% |
PTC TherapeuticsPTCT | Open-market sale10b5-1 plan | 24/12/31 | 25/01/03 | 8,279 sh | $45.16 | $373,879.64 | −3.7% |
PTC TherapeuticsPTCT | Open-market sale10b5-1 plan | 24/04/19 | 24/04/22 | 3,361 sh | $24.89 | $83,655.29 | −1.5% |
PTC TherapeuticsPTCT | Open-market sale10b5-1 plan | 24/04/17 | 24/04/19 | 1,307 sh | $25.14 | $32,857.98 | −0.6% |
PTCT | Open-market sale10b5-1 plan | 24/01/08–24/01/09 | 24/01/10 | 7,680 sh2 trades | $28.90avg. | $221,969.11 | −4.6% |
PTC TherapeuticsPTCT | Open-market sale10b5-1 plan | 24/01/05 | 24/01/09 | 10,107 sh | $27.15 | $274,405.05 | −5.7% |
PTC TherapeuticsPTCT | Open-market sale10b5-1 plan | 23/04/18 | 23/04/20 | 1,211 sh | $52.04 | $63,020.44 | −1.2% |
PTCT | Open-market sale | 23/01/10–23/01/11 | 23/01/12 | 4,517 sh2 trades | $43.64avg. | $197,123.73 | −5.5% |
